Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Evaluating remote fine-tuning of hearing aids for Danish adults

Official title: Exploring the Effectiveness and Acceptability of Remote Fine-Tuning of Hearing Aids in Danish Adults: A Non-blinded, Non-inferiority Randomized Controlled Trial With an Embedded Qualitative Study

Run by Zealand University Hospital · NCT06992778 · Data updated 2026-11-12

This study is testing if adjusting hearing aids through a smartphone app at home is just as effective and satisfying for Danish adults as getting adjustments in person at a clinic.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment120 (estimated)
SponsorZealand University Hospital
Academic / other
Locations1 site (Køge)
StatusRecruiting
StartedMay 27, 2025
Main results expectedMarch 31, 2027
Study endsMarch 31, 2027
Registry record updatedSeptember 18, 2026
Trial IDNCT06992778 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are Danish-speaking adults over 18 with hearing loss who are comfortable using smartphones.

Probably not a fit

Patients with tinnitus requiring treatment, Ménière disease, or those needing in-the-ear hearing aids may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to assess the effectiveness and user satisfaction of remote fine-tuning of hearing aids using a smartphone app compared to traditional face-to-face adjustments. Participants will be randomized into two groups: one receiving remote adjustments from home and the other attending in-person sessions at a clinic. The study will include five consultations over three months, with both self-reported and objective measures of hearing aid outcomes being collected. Additionally, a qualitative substudy will explore user experiences to provide insights into the acceptability and usability of the remote fine-tuning approach.

Why it matters

Potential benefit: If successful, this study could enhance the accessibility and convenience of hearing aid adjustments for patients.

How similar studies have gone: Other studies have shown promise in teleaudiology approaches, suggesting potential success for this remote fine-tuning method.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult patients with hearing loss who desire HA treatment (+18 of age).
* Danish language skills both written and oral.
* Acquisition of digital proficiency in terms of being familiar with operating a smartphone, including navigating menus, opening and closing apps, and interacting with the touchscreen with capabilities for audio and video calls.
* Access to a smartphone that are compatible with manufacturers' system requirements.
* Access to a stable network connection on the mobile device, with either Wi-Fi or mobile data.

Exclusion Criteria:

* Patients with tinnitus requiring treatment or scoring more than 58 in the 'Tinnitus Handicap Inventory' (THI) grading system.
* Patients with Ménière disease, due to its complications and symptoms as dizziness, balance problems and fluctuating hearing loss, that can affect the HA treatment.
* Patients who will receive in-the-ear (ITE) hearing aids, due to potential limitations in connectivity for remote fine-tuning.
* Patients which are recommended/offered unilateral HA treatment.

Where it's running

  • Zealand University Hospital
    Køge, Denmark
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.